COGNITIVE IMPAIRMENT AFTER THE HEMORRHAGIC AND ISCHEMIC STROKE: IS IT POSSIBLE TO MINIMIZE ITS DEVELOPMENT ALREADY IN INTENSIVE CARE?
Authors:
- Yaroslav BondarenkoYaroslav Bondarenko
- Denys KulykDKDenys Kulyk
- Oksana KaukOKOksana Kauk
Open Access
- 18 April 2025
- journal article
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 51,p. 862-876
Abstract
Stroke is one of the leading causes of disability and cognitive decline, significantly affecting patients' quality of life. Post-stroke cognitive impairment (PSCI) can range from mild memory problems to severe dementia, making early intervention crucial for improving recovery outcomes. However, the effectiveness of early neuroprotective strategies in intensive care is not well studied, and standardized treatment protocols are lacking. This study aimed to assess whether cognitive impairment in stroke patients can be minimized through early interventions in the intensive care unit (ICU). The research was conducted in a stroke unit in Kharkiv, Ukraine, and included 15 patients aged 37 to 91 years. All participants had a confirmed diagnosis of ischemic or hemorrhagic stroke and were monitored for 2 to 6 weeks. Treatment focused on maintaining stable cerebral perfusion (MAP ≥ 90 mmHg), ensuring adequate oxygenation (SpO₂ ≥ 95%), and introducing early rehabilitation techniques. The results showed that early interventions improved cognitive function, especially in patients with ischemic stroke. Maintaining blood flow and oxygen levels helped reduce ischemic brain damage, while early rehabilitation promoted cognitive recovery. These findings suggest that targeted neuroprotective strategies in intensive care can help prevent severe cognitive decline in stroke patients. Further research is needed to develop standardized treatment guidelines.Keywords
This publication has 20 references indexed in Scilit:
- Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialThe Lancet, 2024
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysisThe Lancet Healthy Longevity, 2023
- Association between diabetes mellitus and post‐stroke cognitive impairmentJournal of Diabetes Investigation, 2022
- Occupational therapy for cognitive impairment in stroke patientsCochrane Database of Systematic Reviews, 2022
- Effect of acupuncture treatment on post-stroke cognitive impairmentMedicine, 2020
- Potential of stem cell therapy in intracerebral hemorrhageMolecular Biology Reports, 2020
- Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depressionThe Lancet Diabetes & Endocrinology, 2020
- Stroke, cerebrovascular diseases and vascular cognitive impairment in AfricaBrain Research Bulletin, 2019
- Stroke injury, cognitive impairment and vascular dementiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016